Dear Editors,

This is an interesting case of a 37-year-old woman with no relevant medical history who presented to our clinic for a 2-year history of a tender, slowly enlarging, subcutaneous mass on her mons pubis. Clinically, the tumor was skin colored, well circumscribed, and mobile. A computed tomography scan of the pelvis showed an intermediate density subdermal and subcutaneous mass of the anterior mons pubis. The patient was referred to the gynecology department and underwent an excision, which revealed a superficial, 4.0 × 5.0 cm solid mass embedded in the subcutaneous fat of the mons pubis.

Grossly, the mass was pale, smooth, and solid. Microscopically, the tumor showed a well-circumscribed lesion composed of bundles of hyalinized collagen with an embedded hypocellular bland spindle cell proliferation and scattered mast cells ([Fig. 1](#f0005){ref-type="fig"}A and B). Immunohistochemistry testing showed that the mass stained lesional cells diffusely and intensely for CD34 ([Fig. 2](#f0010){ref-type="fig"}) and demonstrated retention of Rb protein. The tumor was negative for desmin, EMA, SMA, STAT6 and ER. The final diagnosis was spindle cell proliferation, most consistent with mammary-type myofibroblastoma. The patient was seen in follow-up several weeks later, and her postoperative course was unremarkable, but follow-up with the gynecology department was recommended.Fig. 1Hematoxylin and eosin staining with (A) original magnification 4× and (B) original magnification 10× showing a well-circumscribed lesion with parallel bundles of thick and hyalinized collagen with an embedded hypocellular bland spindle cell proliferation with scattered mast cells.Fig. 2Immunohistochemistry test results showed that the mass stained lesional cells diffusely and intensely positive for CD34 (depicted in image) and demonstrated retention of RB protein. The tumor was negative for desmin, EMA, SMA, STAT6, and estrogen receptor.

Initially described in 1987, myofibroblastoma is a benign mesenchymal tumor that occurs in the breast ([@b0015]). Histologically, myofibroblastomas are composed of spindle cells with stroma containing mast cells ([@b0010]). With immunohistochemistry testing, these tumors stain positive for CD34 and desmin ([@b0015]). Mammary-type myofibroblastoma is a histologically identical, yet rare, tumor that occurs outside of the breast. Mammary-type myofibroblastoma was first described in a series of nine patients in 2001 and has since been described in more than 160 cases ([@b0005], [@b0010]).

Extramammary, or mammary-type, myofibroblastomas often occur along the embryonic milk line, a phenomenon that remains poorly understood ([@b0010]). These tumors occur in patients in their fourth or fifth generation and present as a slow-growing, asymptomatic mass in the groin or inguinal region ([@b0005]). Grossly, mammary-type myofibroblastomas are well defined and gray or yellow. Histologically, tumors are composed of bundles of spindle cells with small nuclei and faint cytoplasm admixed with adipocytes and hyalinized collagen. Immunohistochemistry test results are usually positive for CD34 and desmin with loss of Rb expression in the nucleus ([@b0005]).

This case represents a unique clinical and histologic presentation of a rare, benign spindle neoplasm, favored to represent a mammary-type myofibroblastoma. This neoplasm was excised from the mons pubis, occurring like a mammary-type myofibroblastoma near the embryonic milk line. These tumors are most often reported as painless, but this patient presented with a tender, slowly enlarging mass. Histologically, this case also deviates from classic mammary-type myofibroblastoma by demonstrating retention of CD34 and Rb and loss of desmin.

In the largest case series of mammary-type myofibroblastoma, both CD34 and desmin are positive in 89% and 91% of cases, respectively ([@b0005]). In 92% of reported cases of mammary-type myofibroblastoma, there is loss of Rb expression ([@b0005]). In this case, a computed tomography scan allowed visualization of the well-circumscribed subcutaneous mass on the mons pubis and its deepest borders, permitting immediate excision without initial biopsy. This case is unique in that histology favored a spindle cell neoplasm with immunohistochemistry test results exhibiting positivity for CD34, retention of Rb, and negativity for desmin ([@b0005]). Although rare, these benign neoplasms are generally diagnosed and cured with excision and have a low risk of recurrence.

Histologically, mammary-type myofibroblastomas are related to spindle cell lipomas and cellular angiofibromas. These three entities may exist on a spectrum because they demonstrate a loss of RB1 and deletion of 13q. Spindle cell lipomas occur on the neck and shoulders of males and stain positive for CD34 and negative for desmin. They often contain wispy collagen, as opposed to the thick collagen described in mammary-type myofibroblastoma ([@b0005]). Additionally, in myofibroblastomas, the cells are arranged in elongated fascicles with variable density of cells. Cellular angiofibromas can be differentiated from mammary-type myofibroblastomas because they have wide hyalinized vessel walls, wispy collagen, smooth stroma, and fewer adipocytes ([@b0005]). The differential should also include dermatofibromasarcoma protuberans, a rare soft tissue sarcoma that is often more infiltrative than a classic mammary-type myofibroblastoma. In addition, its cells stain positive for CD34 ad negative for desmin. Classically, desmin expression is highly suggestive of mammary-type myofibroblastoma.

This case is a unique clinical and histologic presentation of a subcutaneous spindle cell neoplasm occurring on the anterior mons pubis and favored to represent an unusual mammary-type myofibroblastoma. Mammary-type myofibroblastoma is a rare neoplasm, and diagnosis should be based on careful consideration of clinical, histologic, and molecular findings. Although this case aligns in part with a mammary-type myofibroblastoma, it represents a distinctive and rare entity histologically by exhibiting positivity for CD34, retention of Rb, and negativity for desmin ([@b0005]). Although rare, these benign neoplasms are generally diagnosed and cured with excision and have low risk of recurrence.
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